Given the downregulation of RUNX3 expression in CBF AML patients, and to fully assess its importance in normal human myeloid development, the effects of RUNX3 KD in cell growth and differentiation were further determined. The gene discussed is RUNX3; the disease is acute myeloid leukemia.